Newsroom

News

An international research team from TWINCORE - Centre for Experimental and Clinical Infection Research, a joint facility of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Hannover Medical School, describes the dual effect of the endogenous substance itaconic acid, which is both antiviral and anti-inflammatory. Their study, which has now appeared in the journal PLoS Pathogens, opens up perspectives for possible therapeutic applications of itaconic acid against severe courses of disease in viral infections.

17.02.2022

HZI Campus

TWINCORE

Fruchtkörper von Myxobakterien unter dem Lichtmikroskop

News

Pharma-backed incubator INCATE selected the HZI start-up project Myxobiotics as one of the first start-ups to get support. Myxobiotics develops a new class of antibiotics against Acinetobacter baumannii, which causes severe, difficult-to-treat respiratory infections. Myxobiotics’ approach is based on a new class of natural compounds (cystobactamids) discovered and developed as antibacterial agents by Prof Rolf Müller and Prof Mark Brönstrup and their teams at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Helmholtz Centre for Infection Research (HZI), together with Dr Thomas Hesterkamp and Evotec. The HIPS is a site of the HZI in collaboration with Saarland University.

04.02.2022

HZI Campus

HIPS

News

The Minister President of Lower Saxony, Stephan Weil, visited the Helmholtz Centre for Infection Research (HZI) today, 4 February 2022. The visit focused on the current challenges and innovative approaches, especially in combating the SARS-CoV-2 pandemic, and the future development of infection research in Lower Saxony. He also delivered a message of thanks to the scientists at the research centre in Braunschweig.

04.02.2022

HZI Campus

News

Viruses are mostly encountered as pathogens. However, virus-based vaccination platforms can also help to provide protection from different diseases. In a mouse model, researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig together with national and international partners including the German Center for Infection Research (DZIF), the German Primate Center – Leibniz Institute for Primate Research (DPZ), the Technische Universität Braunschweig and the University of Rijeka, Croatia, have developed a novel cytomegalovirus-based vaccine against different respiratory viruses. A single dose of the vaccine that consists of a cytomegalovirus that incorporates genes from coronavirus or influenza A efficiently protected mice from the respiratory infections. The results on the vaccine candidate, which is not yet market-ready, were published in the journal Cellular & Molecular Immunity.

17.01.2022

HZI Campus

News

Principal Investigator Mathias Munschauer aims to better understand SARS-CoV-2. He now receives funding of 1.5 million euros for his research project “COVIDecode” from the European Research Council (ERC). Munschauer is the third scientist at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg to be awarded an ERC grant.

10.01.2022

HIRI

News

Silke Tannapfel, former Administrative Director, will leave the Helmholtz Centre for Infection Research (HZI) in Braunschweig on 31 December 2021 to take on new professional challenges as Ministerial Director in the Hessian Ministry of Higher Education, Research and the Arts. Elisabeth Gerndt, authorised signatory and head of the Finance and Controlling Department at the HZI, is taking over the position of acting Administrative Director.

15.12.2021

HZI Campus

Back to the first page
...
50
51
52
53
...
153

HZI in the media

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz Zentrums für Infektionsforschung in Braunschweig und Professor für

01.03.2026

EUROPE SAYS

... Körperzellen. Damit tragen wir, wie das Helmholtz-Zentrum für Infektionsforschung (HZI) es treffend beschreibt, unseren „ganz ...

27.02.2026

MSN Deutschland

Eine Impfung bringt das Immunsystem in Stellung, bevor der echte Erreger kommt. Erfahren Sie, wie ...

26.02.2026

Apotheken Umschau

Livia V. Patrono, one of the senior authors at the Helmholtz Institute for One Health (HIOH) in Germany, said in a statement .

The research

25.02.2026

IFL Science

says Livia Patrono, a veterinarian and disease ecologist at Helmholtz Institute for One Health in Greifswald, Germany. In 2012, an infected

24.02.2026

Science News

... Dr. rer. nat. Jakob Wirbel vom Helmholtz-Zentrum für Infektionsforschung (Braunschweig). Das Experiment aus Stanford sei ...

20.02.2026

Deutsches Ärzteblatt

... unseres Immunsystems zu entziehen. Strukturbiologen des Helmholtz-Zentrums für Infektionsforschung (HZI) konnten nun mittels ...

18.02.2026

Bionity.COM

of our immune system. Structural biologists at the Helmholtz Center for Infection Research (HZI) have now used cryo-electron microscopy to

16.02.2026

Phys.org

Was es mit Mpox – früher Affenpocken genannt – auf sich hat, welche Symptome erkrankte Personen haben und wie man sich anstecken kann.

13.02.2026

Apotheken Umschau

Julia Port, research group leader at Germany's Helmholtz Center for Infection Research.

"Ongoing outbreaks—particularly those driven by

12.02.2026

Medical Xpress

... Livia Patrono, laut einer Mitteilung des beteiligten Helmholtz-Instituts für One Health (HIOH): Denn dadurch ...

12.02.2026

n-tv

... für den Neubau der Klinik für Strahlentherapie Würzburg sowie für das Helmholtz-Institut für RNA-basierte ...

12.02.2026

Main-Post - Karlstadt

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.